Acid Reflux and Oesophageal Cancer
Barrett’s metaplasia is one of the commonest premalignant lesions in the western world following colorectal adenomas. One in 50 of the adult population develops Barrett’s as a consequence of chronic gastro-oesophageal reflux. The mucosal inflammation seen within patients with gastro-oesophageal reflux seems likely to drive the growth of the metaplastic mucosa and also help direct further oncological change, yet the molecular events that characterize the pathway from inflammation to metaplasia to dysplasia and adenocarcinoma are poorly understood. There is hope that understanding the role of oesophageal inflammation will provide important insight into the development of Barrett's metaplasia and oesophageal cancer. This chapter will discuss the inflammation seen within context of Barrett’s oesophagus and also clinical trials which hope to address this common premalignant disease. There are several ongoing clinical trials which are aiming to provide data using anti-inflammatory therapies to tackle this important premalignant condition. There is new data presented which suggests that data from the aspirin esomeprazole chemoprevention trial (AspECT) may hold the clue to disease treatment and that the cytokine TNF-α seems to be a key signalling molecule in the metaplasia–dysplasia–carcinoma sequence. Specifically it appears that both epigenetic and inherited genetics cooperate to modulate the prognosis.
KeywordsBarrett’s metaplasia Oesophageal adenocarcinoma Inflammation Non-steroid anti-inflammatories Proton pump inhibitors
- Cuzick Jack, Otto Florian, Baron John A, Brown Powel H, Burn John, Greenwald Peter, Jankowski Janusz, Vecchia Carlo La, Meyskens Frank, Senn Hans Jörg, Thun Michael (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10:501–507PubMedCrossRefGoogle Scholar
- Duggan SP et al (2010) An integrative genomic approach in oesophageal cells identifies TRB3 as a bile acid response gene, which regulates NF-kappaB activation and cytokine levels. Carcinogenesis 31(5): 936-945Google Scholar
- Moayyedi P, Jankowski JA (2010) Does long-term aspirin prevent cancer? BMJ 341Google Scholar
- Nguyen GH et al (2010) Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res 16(23):5824–5834Google Scholar
- Saadi A et al (2009) Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. PNAS 107(5):2177–2182 Google Scholar